Betaseron is a Kit in the Human Prescription Drug category. It is labeled and distributed by Bayer Healthcare Pharmaceuticals Inc.. The primary component is .
Product ID | 50419-524_39d087d4-1cab-44fa-8124-ad682c44faa0 |
NDC | 50419-524 |
Product Type | Human Prescription Drug |
Proprietary Name | Betaseron |
Generic Name | Interferon Beta-1b |
Dosage Form | Kit |
Marketing Start Date | 2009-07-09 |
Marketing Category | BLA / BLA |
Application Number | BLA103471 |
Labeler Name | Bayer HealthCare Pharmaceuticals Inc. |
Active Ingredient Strength | 0 |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2009-08-11 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA103471 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2009-08-11 |
Marketing Category | BLA |
Application Number | BLA103471 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2009-07-09 |
Marketing Category | BLA |
Application Number | BLA103471 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2009-08-11 |
Marketing Category | BLA |
Application Number | BLA103471 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2009-08-11 |
Marketing Category | BLA |
Application Number | BLA103471 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2016-09-01 |
SPL SET ID: | 66311f74-0472-4fa3-848a-06002ca0def5 |
Manufacturer | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
50419-524 | Betaseron | interferon beta-1b |
0078-0569 | EXTAVIA | Interferon beta-1b |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
BETASERON 74331750 1794622 Live/Registered |
BAYER INTELLECTUAL PROPERTY GMBH 1992-11-13 |
BETASERON 73688342 1490782 Dead/Cancelled |
TRITON BIOSCIENCES INC. 1987-10-05 |
BETASERON 73499089 1381000 Dead/Cancelled |
CETUS CORPORATION 1984-09-12 |